SCHEMBL24681052

SCHEMBL24681052

c1ccc(-c2nc(-c3cnccn3)no2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.73
▸ NPC1 O15118 8/20 0.73
▸ PKM P14618 7/20 0.73
▸ SMN1; SMN2 Q16637 8/20 0.69
▸ TP53 P04637 7/20 0.69
▸ ALDH1A1 P00352 4/20 0.65
▸ MAPT P10636 4/20 0.65
▸ HSD17B10 Q99714 3/20 0.65
▸ TSHR P16473 3/20 0.65
▸ KDM4E B2RXH2 2/20 0.65
▸ HPGD P15428 2/20 0.65
▸ LMNA P02545 1/20 0.65
▸ KLF5 Q13887 1/20 0.65
▸ NR1H4 Q96RI1 2/20 0.58
▸ NFKB1 P19838 1/20 0.55
▸ NFKB2 Q00653 1/20 0.55
▸ RELA Q04206 1/20 0.55
▸ ATR Q13535 1/20 0.54
▸ CHRNB2 P17787 1/20 0.54
▸ CHRNA5 P30532 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23657562 0.84 RAB9A (1.00) RAB9ANPC1PKMSMN1; SMN2TP53
SCHEMBL5959953 0.81 PKM (1.00) RAB9ANPC1PKMSMN1; SMN2TP53
SCHEMBL1423031 0.79 CHRNB2 (0.71) RAB9ANPC1PKMSMN1; SMN2TP53
SCHEMBL2463534 0.78 SMN1; SMN2 (0.93) RAB9ANPC1SMN1; SMN2TP53ALDH1A1
SCHEMBL2460914 0.78 NPC1 (0.74) RAB9ANPC1PKMSMN1; SMN2TP53
Dimethylamine SCHEMBL4192736 0.76 PKM (0.88) RAB9ANPC1PKMSMN1; SMN2TP53
SCHEMBL4186570 0.75 TP53 (0.74) RAB9ANPC1PKMSMN1; SMN2TP53
SCHEMBL3796996 0.75 SMN1; SMN2 (1.00) RAB9ANPC1PKMSMN1; SMN2TP53
SCHEMBL166615 0.74 CYP2A6 (0.52) RAB9AALDH1A1KDM4E
SCHEMBL29904375 0.74 CYP2A6 (0.52) RAB9AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4059932-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2022-09-21 — — EP disclosed
Send feedback